entresto 24/26
novartis new zealand ltd - sacubitril/valsartan 50mg (as sodium hydrate complex, contains 24.3 mg sacubitril and 25.7 mg valsartan); ; - film coated tablet - 24.3 mg/25.7 mg - active: sacubitril/valsartan 50mg (as sodium hydrate complex, contains 24.3 mg sacubitril and 25.7 mg valsartan) excipient: colloidal silicon dioxide crospovidone hyprolose basic coating premix, white basic coating premix, red basic coating premix, black magnesium stearate microcrystalline cellulose purified talc purified water - entresto is indicated in adult patients with chronic heart failure (nyha class ii-iv). benefits are most clearly evident in patients with left ventricular ejection fraction (lvef) below normal. lvef is a variable measure, so use clinical judgment in deciding whom to treat
entresto 49/51
novartis new zealand ltd - sacubitril/valsartan 100mg (as sodium hydrate complex, contains 48.6 mg sacubitril and 51.4 mg valsartan); ; - film coated tablet - 48.6 mg/51.4 mg - active: sacubitril/valsartan 100mg (as sodium hydrate complex, contains 48.6 mg sacubitril and 51.4 mg valsartan) excipient: colloidal silicon dioxide crospovidone hyprolose basic coating premix, white basic coating premix, yellow basic coating premix, red magnesium stearate microcrystalline cellulose purified talc purified water - entresto is indicated in adult patients with chronic heart failure (nyha class ii-iv). benefits are most clearly evident in patients with left ventricular ejection fraction (lvef) below normal. lvef is a variable measure, so use clinical judgment in deciding whom to treat
entresto 97/103
novartis new zealand ltd - sacubitril/valsartan 200mg (as sodium hydrate complex, contains 97.2 mg sacubitril and 102.8 mg valsartan); ; - film coated tablet - 97.2 mg/102.8 mg - active: sacubitril/valsartan 200mg (as sodium hydrate complex, contains 97.2 mg sacubitril and 102.8 mg valsartan) excipient: colloidal silicon dioxide crospovidone hyprolose basic coating mixture, white basic coating mixture, red basic coating mixture, black magnesium stearate microcrystalline cellulose purified talc purified water - entresto is indicated in adult patients with chronic heart failure (nyha class ii-iv). benefits are most clearly evident in patients with left ventricular ejection fraction (lvef) below normal. lvef is a variable measure, so use clinical judgment in deciding whom to treat
apo-valsartan hctz 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack
apotex pty ltd - hydrochlorothiazide,valsartan -
apo-valsartan hctz 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack
apotex pty ltd - hydrochlorothiazide,valsartan -
chemmart candesartan candesartan cilexetil 8 mg tablet blister pack
apotex pty ltd - candesartan cilexetil -
chemmart candesartan candesartan cilexetil 32 mg tablet blister pack
apotex pty ltd - candesartan cilexetil -
chemmart candesartan candesartan cilexetil 16 mg tablet blister pack
apotex pty ltd - candesartan cilexetil -
chemmart candesartan candesartan cilexetil 4 mg tablet blister pack
apotex pty ltd - candesartan cilexetil -
terry white chemists candesartan candesartan cilexetil 4 mg tablet blister pack
apotex pty ltd - candesartan cilexetil -